Mechanical shear stress and leukocyte phenotype and function: Implications for ventricular assist device development and use by Cathy, Thornton
 Cronfa -  Swansea University Open Access Repository
   
_____________________________________________________________
   
This is an author produced version of a paper published in:
International Journal of Artificial Organs
                                          
   





Thornton, C. (in press).  Mechanical Shear Stress and Leukocyte Phenotype and Function: Implications for VAD










This item is brought to you by Swansea University. Any person downloading material is agreeing to abide by the terms
of the repository licence. Copies of full text items may be used or reproduced in any format or medium, without prior
permission for personal research or study, educational or non-commercial purposes only. The copyright for any work
remains with the original author unless otherwise specified. The full-text must not be sold in any format or medium
without the formal permission of the copyright holder.
 
Permission for multiple reproductions should be obtained from the original author.
 






Mechanical Shear Stress and Leukocyte Phenotype and Function: Implications for VAD 
Development and Use 
Gemma Radley1,2, Sabrina Ali2, Ina Laura Pieper1,3 and Catherine A Thornton1 
1Swansea University Medical School, SA2 8PP, Swansea, UK 
2Calon Cardio-Technology Ltd, Institute of Life Science, SA2 8PP, Swansea, UK 
3Scandinavian Real Heart AB, Västerås, Sweden 
 
Running title: Mechanical trauma to leukocytes 
Corresponding Author: 
Prof Cathy Thornton 
Room 214 Institute of Life Science 1,  
Swansea University Medical School 
Singleton Park, 
SA2 8PP, Swansea, 
United Kingdom 
Email: c.a.thornton@swansea.ac.uk  
Phone: +44 (0) 1792 602122 
 













Heart failure (HF) remains a disease of ever increasing prevalence in the modern world. 
Patients with end-stage HF are being referred increasingly for mechanical circulatory support 
(MCS). MCS can assist patients who are ineligible for transplant and stabilise eligible patients 
prior to transplantation. It is also used during cardiopulmonary bypass (CPB) surgery to 
maintain circulation whilst operating on the heart. Whilst MCS can stabilise HF and improve 
quality of life, complications such as infection and thrombosis remain a common risk. 
Leukocytes can contribute to both of these complications. Contact with foreign surfaces and 
the introduction of artificial mechanical shear stress can lead to activation of leukocytes, 
reduced functionality, and the release of pro-inflammatory and pro-thrombogenic 
microparticles. Assessing the impact of mechanical trauma to leukocytes is largely overlooked 
in comparison to red blood cells and platelets. This review provides an overview of the 
available literature on the effects of in vitro to clinical MCS systems on leukocyte phenotype 
and function. One purpose of this review is to emphasise the importance of studying 
mechanical trauma to leukocytes to better understand the occurrence of adverse events during 
MCS.   
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Leukocytes, commonly known as white blood cells (WBCs), are cells of the immune system 
responsible for host defence (1). The main subsets of leukocytes can be defined as 
polymorphonuclear (PMN) - neutrophils, eosinophils, and basophils collectively known as 
granulocytes - or mononuclear - monocytes and lymphocytes. Functional differences determine 
the contribution of each cell type to innate and adaptive immunity. These cell types share the 
feature of responding to various stimuli to produce signature pro- and anti-inflammatory 
mediators called cytokines that transduce cell responses in receptor bearing target cells of both 
haematopoietic and non-haematopoietic origin (1). Studies of the effects of mechanical shear 
stress on leukocytes tend to focus on neutrophils, monocytes and lymphocytes, especially T 
cells, because of their contribution to inflammation, thrombosis and immune regulation and 
their relative abundance in human blood. 
Given the vital contribution of these cell types to host defence, changes in environmental 
conditions, such as mechanical shear stress, might alter leukocyte function with potentially 
catastrophic effects. Infection is a common complication ventricular assist devices (VADs) and 
rates are reported to be approximately 7% in the HeartMate II (HMII; Abbott Laboratories) 
and HVAD (HeartWare Inc., Framingham, MA, USA) (2, 3), with the HeartMate 3 (HM3; 
Abbott Laboratories, Illinois, USA) showing rates of 22-36% (4, 5). This is often due to 
infection at the driveline exit site, but there is evidence that the immune system of patients 
receiving mechanical circulatory support (MCS) is compromised compared to healthy people 
(6). For example, early studies reported reduced cellular immunity (7) and deactivation of 
leukocytes (8) in HeartMate XVE VAD patients leading to an impairment of leukocyte function 
and the inability to elicit an effective attack against bacterial and fungal infections leading to 
impaired recovery, sepsis, and multiple organ failure.  
High levels of artificial mechanical stress produced by a VAD disrupts cells leading to damage, 
apoptosis, and stress-induced microparticle (MP) formation which have strong inflammatory 
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and pro-thrombotic properties (9). Device thrombosis is a common complication in VADs 
occurring in with 2-3% of patients (10-13). The most recent VAD to enter clinical use is the 
HM3 which, so far, has been free of device thrombosis (4) but ischaemic stroke remains a 
problem (5).  
The purpose of this review is to provide an overview of the effects of mechanical circulatory 
support (MCS) devices on leukocytes and consider the mechanisms by which shear stress might 
alter leukocyte phenotype and function. A quick reference table for the content is available in 
Table 1. 
The pivotal role of leukocytes in MCS outcomes 
The primary function of the immune system is to protect the body from foreign invaders. MCS 
devices fit into the category of foreign invaders and how leukocytes respond to it highly 
influences the outcome. The most abundant human blood leukocytes are neutrophils (50-60%) 
and are essential for the innate immune response. Neutrophils typically are the first leukocyte 
recruited to an inflammatory site where their role is elimination of pathogens through 
phagocytosis, production of reactive-oxygen species (ROS), and the activity of granule 
contents, for example myeloperoxidase, elastase, and defensins (14).  
Neutrophils are the first leukocyte type to interact with MCS devices and their response is 
dependent largely on biomaterial and microenvironment which affects subsequent events (15). 
The pre-existing inflammatory state of the recipient might prime neutrophils for exacerbated 
activation upon exposure to mechanical shear stress. Such excessive stimulation of neutrophils 
by MCS might contribute to the occurrence of sepsis, multiple organ failure (16), the formation 
of thrombosis (17).  
Monocytes account for 2-10% of all blood leukocytes and quickly follow neutrophils to 
infected or damaged tissues. On migration into tissues, monocytes undergo differentiation into 
macrophages which provide protection through phagocytosis, cytokine production, and antigen 
5 
 
presentation. Macrophages are central to the resolution of inflammation via phagocytosis of 
dying neutrophils and provide a link to the adaptive immune response through antigen 
presentation (18). However, MCS devices due to their size can’t be removed in the same 
fashion as pathogens, leading to ‘frustrated phagocytosis’ by macrophages and the creation of 
an impermeable layer between host and device (15). This layer can grow to block the device 
and cause failure, and emboli can break off leading to stroke. Additionally, activated 
monocytes/macrophages express tissue factor, an activator of the intrinsic coagulation cascade 
(19). Shear stress causes the formation of monocyte-derived tissue factor bearing- 
microparticles that can contribute to thrombosis (9).  
Cells of the adaptive immune system affect the outcomes of MCS through a less direct 
approach. Lymphocytes provide antigen specificity to the immune response with T 
lymphocytes (T cells) being critical in cell-mediated immunity. The CD4+ T helper subset 
provides cytokines and co-stimulation/inhibition to instruct the tenor of the adaptive immune 
response and the CD8+ cytotoxic T cell subsets kill infected host cells (18).  Damage to 
lymphocytes can cause drastic MCS outcomes such as immunosuppression in patients thereby 
increasing the prevalence of opportunistic infections (20). 
 
Mechanical trauma observed in clinical and animal studies 
Cardiopulmonary bypass (CPB) is pro-inflammatory and activates neutrophils 
The short-term effects of shear stress on leukocytes can be observed in cardiopulmonary bypass 
(CPB). Leukocyte activation is evidenced as an increase in pro-inflammatory cytokines such 
as tumour necrosis factor (TNF)-α, interleukin 6 (IL-6), and interleukin 8 (IL-8) over time 
during CPB, albeit not significantly for TNF-α (21). These increases are evident when using 
both centrifugal flow pumps (CFP) and roller pumps (RP) (22). However, neutrophil activation 
appears more prominent in CFP with more elevated levels of elastase and IL-8 than RP after 2 
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hours (22). Reasons for pump differences remain speculative, but one suggestion is that 
pulsatile perfusion, as slightly by RP (23), offers less cellular disruption through better 
preserving microcirculation (24).  
Ventricular assist devices (VADs) generate microparticles 
CPB temporarily introduces high levels of shear stress to the circulation; VADs do so 
permanently and the effects on leukocytes are more likely to cause complications. VADs 
introduce foreign biomaterials with varying surface finishes that are known to cause leukocyte 
activation (25, 26). Whilst this foreign body response may resolve itself through the building 
of an ‘inert’ biological layer on the device, the non-physiological shear stresses remain 
constant. High levels of shear stress cause microparticle (MP) release from platelets (PMP), 
leukocytes (LMP), and endothelial cells (EMP) (28) and patients implanted with the HMII and 
HVAD all have increased LMPs (27). Given that these devices are very different in terms of 
design (HMII a titanium alloy axial-flow pump with ceramic (ruby) bearings (29); HVAD a 
titanium alloy centrifugal pump with parts made from zirconia (30)), it is likely that high shear 
stress introduced by VADs causes LMP release regardless of design features. Consequently, 
an increase in LMPs independently of leukocyte counts has been suggested as a biomarker for 
vascular inflammation (28).  
MPs are both pro-inflammatory and pro-thrombotic so are potentially involved in VAD-related 
thrombosis and chronic systemic inflammation (32). In VAD patients, monocyte tissue factor 
(TF) expression increases within the first week and returns to normal range within a month 
(31). Monocyte-TF is a potential source of thrombin generation (31) and monocytes can 
produce TF-bearing MPs. Significantly increased levels of MPs in VAD patients could be 
predictive of adverse events (33) although there are yet to be conclusive studies on whether 
these are biomarkers of MCS or vascular inflammation in general.  
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VADs affect leukocyte counts 
In patients implanted with a pneumatic-VAD (PVAD; Abbott Laboratories), HMII or HVAD, 
leukocyte counts increased significantly from already greater than usual pre-operative levels to 
above the normal range at post-operative day (POD) 14. Comparatively, patients who undergo 
CPB display an increased leukocyte count, but this returns to normal by POD 5 (34). Woolley 
et al., speculates that the surgery- and device-induced systemic response is substantial as a 
reduction in the inflammatory response is expected to reduce the number of circulating 
leukocytes by this time (35). Given that ‘frustrated phagocytosis’ is a feature of biomaterial 
implantation, any delayed clearance of neutrophils would prolong their presence and might 
sustain their recruitment (15). By POD60, leukocyte counts fall significantly to below pre-op 
levels in all VAD types (35) which could indicate VAD-mediated recovery to normal healthy 
leukocyte counts, or more concerning, leukocyte reduction due to damage. Controversially, in 
vivo studies of HVAD-implanted in sheep showed that the white blood cell count remained 
within normal range throughout the long-term (90 day) study (36). Notably, there are species 
differences in the relative abundance of different leukocyte subsets with lymphocytes the most 
abundant leukocyte in sheep and neutrophils in humans (37). Analysis of total white blood cell 
count only in sheep might mask VAD-related effects on neutrophils (38).  
VADs activate leukocytes in a device-dependent manner 
As the first line of defence against foreign bodies such as VADs, granulocytes are predisposed 
to upregulation and expression of activation markers. Macrophage antigen-1 (MAC-1) is a 
granulocyte marker for systemic inflammation and has been used as a biomarker in CPB and 
sepsis [16,17]. MAC-1 expression on granulocytes was increased significantly in HMII at POD 
14 and did not return to pre-operative levels until POD 120 (35). On the other hand, HVAD 
patients had only a small increase in MAC-1 expression at POD 14 which had returned to pre-
operative levels by POD 60 (35). Patients implanted with the HMII also experienced higher 
rates of infection than the HVAD, likely related to increased MAC-1 expression and MAC-1-
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induced apoptosis of granulocytes. Shear stress rather than biomaterial/surface choice here is 
the more likely explanation for the increased granulocyte activation in the HMII as the 
operating speed is 3-4 times greater than that of the HVAD with smaller gaps and twice the 
range of turbulent stresses (39).  
In animal studies, activation of leukocytes and subsequent aggregation with platelets was 
measured in cows implanted with the HMII. Increases in monocyte tissue factor, monocyte-
platelet and granulocyte-platelet aggregates occurred within the first few days post-operatively. 
While levels decreased over the next 30 days they remained greater than pre-operative levels 
and are suggestive of increased risk of thrombosis (40). Again, the presence of small gaps and 
turbulent stresses in the HMII is likely responsible with thrombus formation around the 
bearings the result (41). 
VAD use can lead to immunosuppression 
Severe side effects of VADs include sepsis and multiple organ failure which are associated 
with chronic inflammation and immunosuppression (16). Potential deactivation of monocytes 
through reduced expression of HLA-DR has been observed in VAD recipients. Loss of HLA-
DR has been postulated as a biomarker for increased risk of patient mortality as patients who 
died had fewer HLA-DR-positive monocytes than those who survived (8). This also might be 
indicative of immunoparalysis which hampers tissue repair for end-organ recovery (42). The 
deactivation of monocytes by VADs might be more likely in patients with pronounced systemic 
inflammation, with introduction of the device activating monocytes to the point of exhaustion 
(8).  
The effects of MCS on T and B cells are much less studied. Implantation of the first generation 
pulsatile flow VADs in humans has been described to cause a selective reduction in CD4+ T 
cells, defective CD3+ T cell proliferative responses to stimuli and higher levels of apoptosis in 
both CD4+ and CD8+ T cells; the link between these and mechanical stress is supported by in 
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vitro studies of the effects of shear stress on T cells (7, 20, 43, 44). The effects of continuous-
flow devices on lymphocytes, while less studied, are suspected to be less severe than pulsatile-
flow devices. The one available study showed increased apoptotic activity in CD4+ T cells up 
to 4 weeks post-operatively which normalised to baseline after 7 weeks (45) rather than 
sustained excessive CD4+ T cell apoptosis linked to a drastic reduction in circulating CD4+ T 
cells in pulsatile devices (20). More recently, a study of infection rates in continuous flow VAD 
(CF-VAD) patients found that patients with infection had much higher numbers of circulating 
regulatory T (Treg) cells than those without infection (46). Oxidative stress was also prominent 
in CF-VAD patients and combined with increased Treg cells could lead to immunosuppression 
and pathogen persistence (46).   
There is very little information on the effects of total artificial hearts (TAH) on leukocytes. In 
one study that observed two patients sustained with long-term TAH, granulocyte function 
remained intact, but both patients became B and T lymphopenic with an initial decrease in the 
ratio of helper to cytotoxic T cells (47). Whilst identifying changes in leukocytes by MCS is 
beneficial to modifying care during use, understanding the mechanisms behind these changes 
benefits design changes by developers.   
In vitro shear stress models 
Several shearing devices have been used during in vitro studies to generate variable shear stress 
conditions and study their effects of leukocytes. Each device type has their advantages and 
disadvantages, but those used in leukocyte activation studies include: 
• Concentric cylinder viscometer: blood is sheared in the annular gap between the inner 
bob and the outer cup (48, 49) 
• Cone and plate viscometer: blood is sheared in the gap between the stationary plate and 
the perpendicular rotating cone (50). 
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• Parallel plate viscometer: blood is sheared in the gap between the stationary plate and 
the rotating parallel plate (51, 52).  
• Microfluidic devices: blood is pushed through micrometre sized channels using syringe 
pumps or other pumps to control flow (53).  
• Mock circulatory loops: blood is circulated through a loop connected to MCS devices 
(38, 54). 
Key findings include the lower tolerance threshold of leukocytes compared to red blood cells. 
Using a concentric cylinder viscometer to shear whole blood in the range of 10 – 60 Pa for 10 
min yielded a decrease in white blood cell viability and count, and increased enzyme release; 
this was at levels much lower than critical for detrimental effects on red blood cells (~ 150 Pa) 
(48, 49). Lower shear stresses but still greater than physiological levels (> 0.6 Pa) cause 
pseudopod retraction and condensed actin distribution (52). Comparable results were seen 
using a cone-and-plate device wherein shear stress (0.15-0.5 Pa) applied to leukocytes adhered 
to a glass surface caused instant pseudopod retraction (50).  
Retraction of pseudopods relates to the phagocytic ability of leukocytes. The phagocytic ability 
of neutrophils diminishes under high (> 0.6 Pa) compared to low (0-0.2 Pa) shear stress (52). 
Bacteria were seeded onto discs of cardiovascular device materials and isolated neutrophils 
were added to the discs which were then subjected to shear using a rotating disk system. 
Scanning electron microscopy (SEM) revealed that neutrophils subjected to high shear stress 
became compact and irregularly-shaped, with condensed nuclei and F-actin and were 
apparently incapable of interacting with the bacteria (52). Those subjected to lower shear 
stresses maintained the characteristic multi-lobed nuclei with normal morphology and 
bactericidal activity (52). Another study identified an immediate retraction of neutrophil 
pseudopodia at the application of ~ 0.04 Pa with neutrophil granule velocity significantly 
enhanced by shear stress (0.1 Pa) indicating that the cytoplasm within the cell had become less 
viscous due to cell swelling (53). The continuous application of shear stress enhances random 
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granule velocity and reduces cell stiffness. These phenomena suggest that shear stress mediates 
water entry into the cell thereby reducing F-actin (53), causing cell swelling/lysis (49), and 
depressing T cell activation (55). 
Rotary blood pumps tested for 6h with human blood have shown white blood cell damage 
through trypan blue exclusion in the absence of haemolysis further supporting that white blood 
cells are more vulnerable to mechanical trauma than red blood cells (56). When circulated 
through the CentriMag™ and HMII (Abbott Laboratories), blood elastase concentration 
increased significantly over time, indicating granulocyte activation (57). Our own studies using 
bovine blood circulating through the CentriMag™, RotaFlow (MAQUET Holding B.V. & Co. 
KG, Rastatt, Germany), and VentrAssist™ (Ventracor Ltd., Sydney, Australia) for 6h showed 
an increase in leukocyte-derived microparticles (LMPs), indicative of mechanical damage (54, 
58). Characterisation of these LMPs using ovine blood circulated through the CentriMag™  
identified CD11bbright/HLA-DR- and CD11bdull/HLA-DR+ populations of LMPs which we 
propose come from granulocytes – that were also significantly decreased in number - and T 




Mechanisms of mechanical (de)activation 
The studies mentioned above show that shear stress greatly impacts leukocyte morphology and 
function whether it be high enough to cause destruction (49), or just enough to reduce 
phagocytic ability (52).  Knowing how this happens can benefit the development of MCS to 
encourage leukocytes to work with rather than against the device.  The mechanisms through 
which artificially high shear stress activates or deactivates leukocytes are yet to be fully 
understood. Much of the literature regarding the effects of shear stress is contradictory due 
mostly to variation in the methods used to apply shear stress and to measure its effects. The 
following section aims to summarise what is known about mechanotransduction effects in 
leukocytes. 
Innate immune cells 
Responding to changes in shear forces is a normal feature of leukocyte activity. During 
inflammation, circulating leukocytes must cross the endothelium and migrate into tissues. 
Leukocytes interact with and tether to the endothelial surface most efficiently at around 0.1 – 
0.2 Pa (59). Leukocytes must then produce pseudopodia to allow migration across the 
endothelium and into the tissue. In healthy vasculature, physiological shear of around 0.15 Pa 
(60) induces pseudopod retraction (53) which is dependent on the presence of red blood cells 
(61, 62). This serves to maintain circulating leukocytes in a spherical shape to prevent trapping 
in capillaries and allow normal passage through the microcirculation (50). Therefore, the 
leukocyte shear stress response is a fundamental regulatory mechanism supporting normal 
blood flow and enabling the inflammatory response. 
The principal consequences of neutrophil priming and activation includes cell polarisation with 
the formation of lamellipodia at the leading edge and a uropod trailing edge (63), increased cell 
deformability, expression of integrins/selectins, generation of superoxide anions, and 
degranulation and release of lipid mediators (64). Activation occurs through ligand-induced 
structural changes in receptor molecules that activate intracellular signalling cascades. These 
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control neutrophil adhesion and migration, in part through local regulation of actin 
polymerisation and actin-myosin contraction (61). The Rho family of small GTPases are well-
established key mediators of ligand-induced cytoskeleton changes in motile cells (61, 63). It 
has been suggested that shear stress activates leukocytes through structural changes in the same 
array of molecules in response to physical forces rather than ligand-induced signal transduction 
(65). Examples include stretch-sensitive calcium ion channels, neutrophil polarisation through 
plasma membrane tension, or swelling-induced inflammatory lipid mediator production from 
damaged host cells (65, 66). More recently, guanine nucleotide exchange factor-H1 (GEF-H1) 
has been associated with shear stress activation of neutrophils. GEF regulates actin-myosin-
dependent uropod contractility in leukocytes by promoting GDP-to-GTP exchange on the small 
GTPase RhoA (67). GEF-H1 is activated in response to shear stress to promote spreading, 
crawling, and transmigration of neutrophils (61). Depolymerised GEF-H1 re-localises to the 
uropod to stimulate Rho signalling resulting in intracellular tension and cellular contractility 
(65). 
Notably, repeated mechanical deformation of primed neutrophils can return them to a resting 
state (68). Shear deactivation of neutrophils through retraction of pseudopods can occur at 
around 2.5 Pa but prolonged exposure to fluid shear stress leads to visibly disrupted leukocyte 
structure (62). The particular challenge of MCS devices is the combination of areas of high 
shear stress with low residence time, and areas of low shear stress with long residence times. 
If leukocytes can be differentially and negatively affected by both scenarios, simply lowering 
shear stress is not enough. Neutrophils are the primary effectors of the innate immune response 
and the negative effects on them will have downstream consequences.  
It has been suggested that mechanotransduction mechanisms in monocytes are similar to 
neutrophils as they also form uropods during extravasation (69). Whilst F-actin becomes 
condensed in neutrophils, an increase in its synthesis in monocytes has been observed when 
applying 12 Pa shear stress using a microfluidic pump (70). F-actin is used for pseudopod 
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extension in phagocytosis (71) therefore so it is possible that elevated shear stress underpins 
the ‘frustrated phagocytosis’ noted earlier.  
Adaptive immune cells 
T lymphocytes, the most studied lymphocyte subtype in terms of shear stress, differ 
fundamentally to neutrophils and monocytes as they crawl against blood flow (72). Adhesion 
of T lymphocytes to the blood vessel wall occurs rapidly and firmly – cells must arrest at the 
endothelium and resist shear stress once tethered, which relies on polarised adhesion (72). In 
one study, increasing shear stress from 0.03 to 0.12 Pa decreased the fraction of adherent 
lymphocytes suggesting disruption of the adhesive mechanism between T lymphocyte and 
endothelium (73). When subjected to significantly higher than physiological shear stress (10-
20 Pa) for 10 min, T lymphocytes were no longer able to proliferate on stimulation with the 
lectin phytohaemagglutinin-P (PHA-P) and IL-2 production was diminished (55). This relates 
to the studies in VAD patients that identify defective proliferative responses to stimuli in T 
cells leading to immunosuppression (20). Lectin binding to the T cell surface induces a rise in 
intracellular calcium ions, accompanied by depolarisation of the membrane, and acquisition of 
IL-2 receptors (55). This suggests that high shear disrupts T cell activation through interfering 
with lectin binding or prohibits an IL-2 feedback loop through another mechanism. The cellular 
and molecular mechanisms underpinning this are largely unknown and warrant investigation 





The use of mechanical circulatory devices has revolutionised cardiac surgery and the treatment 
of heart failure. Such devices introduce artificially higher shear stress to the circulatory system 
for prolonged times and can cause cell damage. Research in this area has focused mainly on 
RBC damage through haemolysis measurements (75). However, RBC tolerance to shear is 
relatively high in comparison to that of leukocytes, and also of platelets (76).  
MCS devices affect all leukocyte types, but neutrophils appear to be the most affected. CPB 
activates neutrophils as measured through increased elastase which is a marker of 
degranulation (22). CPB also has been associated with increased circulating pro-inflammatory 
cytokines, particularly IL-8, which chemoattracts neutrophils and prolongs the inflammatory 
response (21). Inflammation rapidly mobilises the release of neutrophils from the bone marrow 
into the blood, leading to an increase in leukocyte count which returns to normal a few days 
after CPB (34). However, leukocyte counts remain elevated at POD 14 in VAD patients 
suggesting a substantial device-induced systemic response that might be affected by the 
introduction of foreign biomaterials, various surface finishes, as well as artificial shear stress 
(26, 35).  
Shear stress affects neutrophils independently of biomaterials as evidenced by increased 
activation of granulocytes in HMII patients compared to the HVAD (35). It is suggested that 
the physical forces of non-physiological shear stress cause structural changes that activate 
granulocytes (65). Activation is marked by an increase in MAC-1 expression as observed in 
the HMII patients (35). Equally, non-physiological shear can return granulocytes to a resting 
state where they are no longer responsive to inflammatory stimuli (68). This is problematic in 
that a reduction in phagocytic ability by granulocytes leaves patients vulnerable to infection, 
and might be why HMII patients suffer recurrent infections (35, 52).  
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Chronic infection, sepsis, and multiple-organ failure are also related to shear stress effects on 
other leukocytes types. Monocytes can react to biomaterials through ‘frustrated phagocytosis’ 
(15) and high shear on monocytes induces F-actin synthesis for pseudopod extension (70). This 
might be why monocyte deactivation occurred (8). Immunosuppression can also occur through 
effects on T cells. In vitro studies have shown that shear stress mediates water entry into cells 
which can cause cell swelling/lysis and depress T cell activation (49, 55). Shear-induced 
swelling of T cells would go towards explaining the high levels of CD4+ and CD8+ cell 
apoptosis in VAD patients (20). Exposure to high shear also diminishes the T cell response to 
inflammatory stimuli (55) which is suggested to be caused by interference with lectin-binding 
by mechanical forces. This has also been noted in VAD patients who showed defective T cell 
proliferative responses to stimuli (7). 
The mechanisms through which shear stress causes activation, and perhaps eventually 
exhaustion, of multiple leukocyte populations are not fully understood. Better understanding 
of these processes would provide data to optimise MCS design and minimise detrimental 
effects on leukocyte function as well as the adverse events that currently accompany the clinical 
use of blood handling medical devices. 
Future outlook 
The development of new test devices that allow modifications of gap size, residence time, shear 
stress, biomaterial types, and surface finish for leukocyte analysis in vitro would prove highly 
beneficial. Such devices would improve the design of MCS devices’ long before implantation 
through providing more information on cellular activation.  Whilst studies on RBCs and 
platelets are clearly beneficial, leukocytes are far more complex in their interactions due to 
their variety and diverse functions. Leukocytes play a role in both infection and thrombosis – 
two common complications of MCS usage – so including analysis of these cell types should 
improve optimisation of device design in terms of thrombogenicity and potentially reduce 
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Figure 1: Relationship between shear stress and changes in leukocyte morphology and 
function. Leukocytes are accustomed to physiological shear stress (0.05 – 1 Pa) throughout 
the circulation allowing them to remain in a resting state until activated by pathogenic stimuli. 
Above these shear levels, leukocyte function is altered through diminished phagocytic ability 
(> 0.6 Pa (52)); deactivation by shear (2.5 Pa (62)); and defective proliferation responses by T 
cells to stimuli (> 10 Pa (55)). Shear above 10 Pa destroys platelets and leukocytes leading to 
the production of microparticles. Red blood cells remain more tolerant to high shear as 





In vitro In vivo Clinical 
CPB VAD TAH 
Inflammation 
& Leukocytes 
↑Complement activation (57) 
↑LMPs (54, 58) 
↑WBC trauma compared to RBC 
in rotary blood pumps (56) 
↑Disrupted WBC morphology 
with increasing shear  (48, 49) 
Normal leukocyte count 
throughout (36) 
↑Proinflammatory 
cytokines (21, 22) 
↑Complement 
activation (22) 
↓WBC count to below normal 
range (35) 
↑LMPs (27, 28) 
  
Neutrophils 
↑Activated LMPs (38) 
↑Elastase levels (57) 
↓Phagocytosis with high shear 
(52) 
↑Depolarisation of neutrophils 
with increasing shear (64, 68) 
Minimum level of shear stress 
for neutrophil deactivation (62) 
GEF-H1 (61, 65) 
↑Cell swelling, increased 
random granule velocity, and 
reduced cell stiffness with 
increasing shear (53) 
↑Neutrophil-platelet 
aggregates (40) 
↑Elastase levels (22) ↑Granulocyte activation (35)   
Monocytes 











↑Activated LMPs (38) 
↑Defective proliferation to 
stimuli (55) 
Effector T cells adhere 
spontaneously under shear in 
the absence of chemokine-
induced activation (74) 
    ↑Activation-induced CD4+ 
apoptosis (7, 20, 45) 
↓CD4/CD8 ratio (20) 
↑Suppresive Tregs (44, 77) 
↑Defective proliferation to 
stimuli (43, 44) 
↑ROS (77) 
↓T cells (47) 
↓CD4/CD8 
ratio (47) 
B lymphocytes         ↓B cells (47) 
 
Table 1. A quick guide to published literature on the effects of MCS on leukocytes 
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